Australia
Incannex begins Phase II trial of combination drug for rheumatoid arthritis
The trial will assess IHL-675A against the respective component APIs, CBD and HCQ, and a placebo.
Recce chooses CMAX for urinary tract infections therapy trial
Children’s Cancer Institute begins trial for childhood brain cancer therapy
Clinuvel reports data from xeroderma pigmentosum therapy trial
Kira gets clearance for bifunctional biologic trial in China, Australia
CuraSen reports positive data from Parkinson’s disease oral therapy trial
Intravacc enrols first subject in intranasal Covid-19 booster trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
